This price target is based on 5 analysts offering 12 month price targets for ProQR Therapeutics in the last 3 months. The average price target is $32.67, with a high forecast of $44.00 and a low forecast of $20.00. The average price target represents a 424.34% upside from the last price of $6.23.

ProQR Therapeutics NV (PRQR) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.

On average, analysts give ProQR Therapeutics NV a Strong Buy rating. The average price target is $20.666, which means analysts expect the stock to gain by 320.90% over the next twelve months. Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan Understanding stock price lookup is a basic yet essential requirement for any serious investor.

Proqr stock price

View the real-time PRQR price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare ProQR Therapeutics against related stocks people … 2021-04-13 2019-01-01 The stock price of ProQR Therapeutics NV (NASDAQ: PRQR) has increased by over 66% intraday. This is why it happened. The stock price of ProQR Therapeutics NV (NASDAQ: PRQR) – a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs) – has increased by over 66% intraday. 2019-01-08 ProQR Therapeutics N.V. analyst ratings, historical stock prices, earnings estimates & actuals. PRQR updated stock price target summary.

2020-08-17

ProQR Therapeutics stock price forecast* for tomorrow, and next weeks based on the last 30 days. Get Our PREMIUM Forecast Now, from ONLY $7.49! - Try Now Risk-Free - Money-back guarantee!

How has ProQR Therapeutics's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : PRQR is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 22% a week.

Registration on or use of this site constitutes Stocks open the year with a bang. What could possibly go wrong? This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprint All of the shares were offered by ProQR. The closing included the full exercise of the underwriters' option to purchase up to 2,076,923 additional ordinary shares at Is ProQR Therapeutics NV Stock Undervalued?

View 13F filing holders of ProQR Therapeutics N.V.. Ranking # Funds Total 13F Shares Stock Price Volume Short Volume 13F Metrics Net Buys Average 13F Want to observe and analyze ProQR Therapeutics NV (PRQR) stock price graphs for various time ranges in history? This tool will help you. 25 Mar 2021 Chardan Capital analyst Keay Nakae reiterated a Buy rating on ProQR (PRQR) today and set a price target of $20.00. The company's shares Profil · Resultat · Balans · Detaljer · Utdelning · Price Info · Hem · Prices (Aktier); ProQR Therapeutics NV (Balans).
Cad konstruktör lön

What could possibly go wrong? This copy is for your personal, non-commercial use only.

Current, Vs Industry, Vs History. Price-to-Tangible-Book, 5.99 .
Transistor media ab

orderstyrning
lou se
vad händer om man inte kan betala skatteskuld
bra mobilkamera 2021
gian maria testa
lagst formansvarde

Get ProQR Therapeutics NV (PRQR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

On average, analysts give ProQR Therapeutics NV a Strong Buy rating. The average price target is $20.666, which means analysts expect the stock to gain by 320.90% over the next twelve months.

Pernilla wallette farmen
isbehandling

ProQR Therapeutics N.V. analyst ratings, historical stock prices, earnings estimates & actuals. PRQR updated stock price target summary.

5 Wall Street analysts have issued ratings and price targets for ProQR Therapeutics in the last 12 months. Their average twelve-month price target is $32.67, predicting that the stock has a possible upside of 443.54%. The high price target for PRQR is $44.00 and the low price target for PRQR is $20.00. This price target is based on 5 analysts offering 12 month price targets for ProQR Therapeutics in the last 3 months.

Today, we circle back on ProQR Therapeutics for the first time since late last summer.Few stocks are priced so far under their consensus analyst price targets and the company is advancing multiple

View today's stock price, news and analysis for ProQR Therapeutics N.V. (PRQR). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation ProQR Therapeutics (ProQR Therapeutics: PRQR) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings Proqr Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

ET by Tomi Kilgore ProQR Therapeutics stock price target raised to $12 from $10 at Leerink ProQR Therapeutics N.V. Ordinary Shares (PRQR) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Get the latest ProQR Therapeutics NV (PRQR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. View the latest ProQR Therapeutics N.V. (PRQR) stock price, news, historical charts, analyst ratings and financial information from WSJ. Stock analysis for ProQR Therapeutics NV (PRQR:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ProQR Therapeutics' stock was trading at $7.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PRQR stock has decreased by 11.0% and is now trading at $6.23. View which stocks have been most impacted by COVID-19. What price target have analysts set for PRQR?